Table 4.

Length of ICU and hospital stay according to reason for ICU admission

	Respiratory N = 66	Colitis N = 14	Cardiovascular N = 13	Metabolic N = 11	Neurological N = 6
Time to ICU discharge (days)	5 [3–11]	4 [3–10]	13 [8–17]	3 [2–5]	5 [3–12]
Admission “likely” related to irAE	7 [4–14]	3 [3–5]	4 [3–7]	3 [3–5]	8 [4–38]
Admission “unlikely” related to irAE	4 [2–8]	4 [2–12]	2 [1–4]	2 [2–2]	4 [2–6]
ICU mortality	19 (28)	0 (0)	0 (0)	3 (27)	1 (17)
Admission “likely” related to irAE	9 (47)			2 (67)	1 (100)
Admission “unlikely” related to irAE	10 (53)			1 (33)	0 (0)
Time to hospital discharge (days)	14 [7–19]	14 [10–43]	13 [8–17]	8 [3–14]	13 [12–20]
Admission “likely” related to irAE	14 [9–21]	22 [9–48]	13 [5–25]	8 [5–8]	13 [12–55]
Admission “unlikely” related to irAE	9 [5–17]	12 [10–19]	13 [9–15]	10 [2–12]	16 [12–20]
Hospital mortality	29 (44)	2 (14)	3 (23)	3 (27)	1 (17)
Admission “likely” related to irAE	12 (41)	0 (0)	0 (0)	2 (67)	1 (100)
Admission “unlikely” related to irAE	17 (59)	2 (100)	3 (100)	1 (33)	0 (0)

Qualitative variables are expressed as n (%) and quantitative variables as median [interquartile range 25%–75%]

^*In nine patients steroids were started before ICU admission

ICU intensive care unit, irAE immune-related adverse event